Congressman David G. Valadao, representing California’s 22nd district, has partnered with Congressman John Duarte from California’s 13th district to introduce the Valley Fever Awareness and Vaccine Development and Manufacturing Act. This legislation focuses on developing a human vaccine for Valley Fever by facilitating its development, approval, licensing, and initial manufacturing.
“Valley Fever has a huge impact on communities throughout the Central Valley and leaves thousands of people sick every year,” said Congressman Valadao. He emphasized his commitment to supporting the legislation initiated by Congressman Duarte to prioritize the vaccine’s development as part of efforts to control the disease’s spread and save lives. Valadao also mentioned his role in the Valley Fever Task Force, highlighting ongoing work towards solutions for Central Valley families’ safety and health.
Congressman Duarte echoed these sentiments, stating that “Valley Fever is a growing public health threat in our communities, and this bill is a critical step toward developing the first human vaccine to protect those most at risk.” He expressed pride in leading this initiative alongside local and national partners to address this disease directly and provide relief to affected regions like the Central Valley.
The background information notes that Congressman Valadao has been an active member of the Valley Fever Task Force since its inception in 2013. The task force aims to raise awareness and push policies against Valley Fever. Last year, Valadao participated in a roundtable hosted by the task force with medical experts and researchers focusing on treatment and vaccine advancements for Valley Fever. Additionally, he co-sponsors the FORWARD Act, which supports research programs aimed at developing new drugs, treatments, and vaccines against Valley Fever.
